Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Asthma

  Free Subscription


Articles published in Respirology

Retrieve available abstracts of 71 articles:
HTML format



Single Articles


    February 2024
  1. MCDONALD CF
    Letter from Australia.
    Respirology. 2024;29:187-188.
    PubMed    


    January 2024
  2. WENG CM, Wu WC, Lee MJ, Chen MC, et al
    Influence of Staphylococcal enterotoxin-specific IgE sensitization on therapeutic efficacy of omalizumab therapy in severe asthma.
    Respirology. 2024 Jan 31. doi: 10.1111/resp.14663.
    PubMed    


  3. MCDONALD VM, Holland AE
    Treatable traits models of care.
    Respirology. 2024;29:24-35.
    PubMed     Abstract available


  4. LAVERCOMBE M
    Recommendations from The Medical Education Editor.
    Respirology. 2024;29:5-7.
    PubMed    


  5. NEFFEN HE, Maillo M
    Letter from Argentina.
    Respirology. 2024;29:82-83.
    PubMed    


  6. SENARATNA CV, Lowe A, Walters EH, Abramson MJ, et al
    Associations of early life and childhood risk factors with obstructive sleep apnoea in middle-age.
    Respirology. 2024;29:63-70.
    PubMed     Abstract available


    December 2023
  7. JENKINS CR
    Mild asthma: Conundrums, complexities and the need to customize care.
    Respirology. 2023 Dec 25. doi: 10.1111/resp.14646.
    PubMed     Abstract available


  8. THOMAS M, Beasley R
    The treatable traits approach to adults with obstructive airways disease in primary and secondary care.
    Respirology. 2023;28:1101-1116.
    PubMed     Abstract available


  9. GRAY DM
    In case you missed it.
    Respirology. 2023;28:1171-1172.
    PubMed    


    November 2023
  10. HATCH M, Lilburn P, Scott C, Ing A, et al
    Safety and efficacy of bronchial thermoplasty in Australia 5 years post-procedure.
    Respirology. 2023;28:1053-1059.
    PubMed     Abstract available


    September 2023
  11. MCDONALD VM, Archbold G, Beyene T, Brew BK, et al
    Asthma and landscape fire smoke: A Thoracic Society of Australia and New Zealand position statement.
    Respirology. 2023 Sep 15. doi: 10.1111/resp.14593.
    PubMed     Abstract available


  12. YASARATNE D, Idrose NS, Dharmage SC
    Asthma in developing countries in the Asia-Pacific Region (APR).
    Respirology. 2023 Sep 13. doi: 10.1111/resp.14590.
    PubMed     Abstract available


  13. BAN AY, Ng BH, Nik Abeed NN
    Letter from Malaysia.
    Respirology. 2023;28:890-891.
    PubMed    


    August 2023
  14. LANGTON D, Politis J, Collyer T, Khung SW, et al
    Benralizumab and mepolizumab treatment outcomes in two severe asthma clinics.
    Respirology. 2023 Aug 28. doi: 10.1111/resp.14578.
    PubMed     Abstract available


  15. KO FWS
    Can we predict asthma exacerbations?
    Respirology. 2023 Aug 23. doi: 10.1111/resp.14583.
    PubMed    


  16. HARVEY ES, Peters MJ
    Asthma registries: Tedious paperwork or a versatile tool for the generation of knowledge-Insights from the Australasian Severe Asthma Registry (ASAR).
    Respirology. 2023 Aug 23. doi: 10.1111/resp.14585.
    PubMed    


  17. REYNOLDS PN, Ansari S, Hernandez-Sebastian R, Boonsawat W, et al
    Towards regional progress: APSR 2022 Big Five Lung Diseases Workshop.
    Respirology. 2023;28:807-816.
    PubMed    


    July 2023
  18. GIBSON PG, McDonald VM, Thomas D
    Treatable traits, combination inhaler therapy and the future of asthma management.
    Respirology. 2023 Jul 30. doi: 10.1111/resp.14556.
    PubMed     Abstract available


  19. KO FWS, Salvi S
    Minimize systemic oral corticosteroids use and reduce harm for patients with asthma.
    Respirology. 2023 Jul 4. doi: 10.1111/resp.14551.
    PubMed    


  20. MALHOTRA A, Razak A
    Risk of childhood asthma in those born small.
    Respirology. 2023 Jul 1. doi: 10.1111/resp.14546.
    PubMed    


    June 2023
  21. KIM HS, Lee SW, Kim JT, Kim JH, et al
    Fetal growth rather than prematurity determines lung function in children with asthma.
    Respirology. 2023 Jun 12. doi: 10.1111/resp.14528.
    PubMed     Abstract available


  22. DHAR R, Rhee CK, Perng DW, Fukunaga K, et al
    The burden of systemic corticosteroid use in asthma management in Asia.
    Respirology. 2023 Jun 10. doi: 10.1111/resp.14533.
    PubMed     Abstract available


    May 2023
  23. SHAH PA, Brightling C
    Biologics for severe asthma-Which, when and why?
    Respirology. 2023 May 24. doi: 10.1111/resp.14520.
    PubMed     Abstract available


  24. HANCOX RJ, Bardin PG
    Asthma research priorities: Listening to everybody.
    Respirology. 2023 May 22. doi: 10.1111/resp.14522.
    PubMed    


  25. BRUSSELLE G, Riemann S, Maes T
    Mepolizumab attenuates ILC2s proliferation and activity in adults with severe eosinophilic asthma.
    Respirology. 2023 May 10. doi: 10.1111/resp.14517.
    PubMed    


  26. BLOOM CI
    Covid-19 pandemic and asthma: What did we learn?
    Respirology. 2023 May 8. doi: 10.1111/resp.14515.
    PubMed     Abstract available


  27. CHI-LEUNG D
    The big 5 respiratory diseases give insight into respiratory health and beyond.
    Respirology. 2023;28:496-497.
    PubMed    


  28. CLEMM HSH
    Letter from Norway.
    Respirology. 2023;28:500-501.
    PubMed    


  29. FLYNN C, Brightling C
    Is FeNOtyping in COPD the path to precision medicine?
    Respirology. 2023;28:421-422.
    PubMed    


  30. FINLAY P, Smith E
    Bronchial provocation testing: Should we look beyond FEV(1) ?
    Respirology. 2023;28:419-420.
    PubMed    


  31. PARKER J, Tzeng A, Wayne S, Haynes JM, et al
    Validation of the clinical utility of sGaw as a response variable in methacholine challenge testing.
    Respirology. 2023;28:437-444.
    PubMed     Abstract available


    April 2023
  32. MALIK B, Bartlett NW, Upham JW, Nichol KS, et al
    Severe asthma ILC2s demonstrate enhanced proliferation that is modified by biologics.
    Respirology. 2023 Apr 28. doi: 10.1111/resp.14506.
    PubMed     Abstract available


  33. KOH J, Phyland D, Ruane L, Avram A, et al
    Lessons from a failed randomized controlled trial of speech pathology intervention in vocal cord dysfunction.
    Respirology. 2023;28:406-408.
    PubMed    


    March 2023
  34. VU HD, Shafuddin E, Willis J, Pallin M, et al
    Monoclonal antibody therapy in cystic fibrosis and asthma.
    Respirology. 2023 Mar 28. doi: 10.1111/resp.14498.
    PubMed    


  35. MAJELLANO EC, Bell RL, Flynn AW, Mckenzie A, et al
    Identifying the asthma research priorities of people with asthma, their carers and other stakeholders.
    Respirology. 2023 Mar 15. doi: 10.1111/resp.14492.
    PubMed     Abstract available


  36. AL-SHAIKHLY T, Murphy RC, Lai Y, Frevert CW, et al
    Sputum periostin is a biomarker of type 2 inflammation but not airway dysfunction in asthma.
    Respirology. 2023 Mar 13. doi: 10.1111/resp.14491.
    PubMed     Abstract available


  37. DONOVAN GM, Wang KCW, Elliot JG, James AL, et al
    Quantifying airway remodelling for research or clinical purposes: How should we normalize for airway size?
    Respirology. 2023;28:223-225.
    PubMed    


  38. COATES AL
    How does one get around many of the confounding factors influencing the response to methacholine?
    Respirology. 2023;28:204-205.
    PubMed    


  39. HENRY C, Boucher M, Boulay ME, Cote A, et al
    The cumulative effect of methacholine on large and small airways when deep inspirations are avoided.
    Respirology. 2023;28:226-235.
    PubMed     Abstract available


    February 2023
  40. ADRISH M, Hanania NA
    Asthma and cardiovascular disease: A bidirectional association?
    Respirology. 2023 Feb 7. doi: 10.1111/resp.14468.
    PubMed    


    January 2023
  41. KO FWS
    Severe asthma, more than that?
    Respirology. 2023 Jan 17. doi: 10.1111/resp.14453.
    PubMed    


  42. YU S, Lee SC, Hong JH, Han CH, et al
    Cardiovascular and cerebrovascular mortality in patients with preceding asthma exacerbation.
    Respirology. 2023 Jan 3. doi: 10.1111/resp.14444.
    PubMed    


  43. HANCOX RJ, Chang CL
    The ill winds of COVID-19: How the pandemic improved respiratory health for some.
    Respirology. 2023;28:13-14.
    PubMed     Abstract available


  44. KO FWS, Lau LHS, Ng SS, Yip TCF, et al
    Respiratory admissions before and during the COVID-19 pandemic with mediation analysis of air pollutants, mask-wearing and influenza rates.
    Respirology. 2023;28:47-55.
    PubMed     Abstract available


    November 2022
  45. GIBSON PG
    Adding some NOVELTY to treatable traits.
    Respirology. 2022;27:912-913.
    PubMed    


  46. AGUSTI A, Rapsomaniki E, Beasley R, Hughes R, et al
    Treatable traits in the NOVELTY study.
    Respirology. 2022;27:929-940.
    PubMed     Abstract available


    October 2022
  47. FOONG RE, Franklin P, Sanna F, Hall GL, et al
    Longitudinal effects of prenatal exposure to plastic-derived chemicals and their metabolites on asthma and lung function from childhood into adulthood.
    Respirology. 2022 Oct 2. doi: 10.1111/resp.14386.
    PubMed     Abstract available


    September 2022
  48. PRICE D, Uthaman T
    What have we learnt from real-life research in asthma and COPD? Standards and novel designs for the future.
    Respirology. 2022 Sep 29. doi: 10.1111/resp.14381.
    PubMed    


  49. ADRISH M, Hanania NA
    Choosing and switching biological agents in severe asthma.
    Respirology. 2022 Sep 26. doi: 10.1111/resp.14377.
    PubMed    


  50. PASSOS NF, Freitas PD, Carvalho-Pinto RM, Cukier A, et al
    Increased physical activity reduces sleep disturbances in asthma: A randomized controlled trial.
    Respirology. 2022 Sep 6. doi: 10.1111/resp.14359.
    PubMed     Abstract available


  51. HASHMI MD, Khan A, Shafiq M
    Bronchial thermoplasty: State of the art.
    Respirology. 2022;27:720-729.
    PubMed     Abstract available


    August 2022
  52. NEDER JA, O'Donnell DE
    The severe asthma-obesity conundrum: Consequences for exertional dyspnoea and exercise tolerance in men and women.
    Respirology. 2022 Aug 17. doi: 10.1111/resp.14346.
    PubMed    


  53. COUILLARD S, Pavord ID, Heaney LG, Petousi N, et al
    Sub-stratification of type-2 high airway disease for therapeutic decision-making: A 'bomb' (blood eosinophils) meets 'magnet' (FeNO) framework.
    Respirology. 2022;27:573-577.
    PubMed    


    July 2022
  54. PITZNER-FABRICIUS A, Clark VL, Backer V, Gibson PG, et al
    Factors associated with 6-min walk distance in severe asthma: A cross-sectional study.
    Respirology. 2022 Jul 10. doi: 10.1111/resp.14323.
    PubMed     Abstract available


  55. WANG KCW, Donovan GM, Saglani S, Mauad T, et al
    Growth of the airway smooth muscle layer from late gestation to childhood is mediated initially by hypertrophy and subsequently hyperplasia.
    Respirology. 2022;27:493-500.
    PubMed     Abstract available


    June 2022
  56. PEREZ-GARCIA J, Pino-Yanes M
    Novel insights into the biological pathways involved in severe asthma.
    Respirology. 2022 Jun 28. doi: 10.1111/resp.14319.
    PubMed    


  57. SANCHEZ-OVANDO S, Pavlidis S, Kermani NZ, Baines KJ, et al
    Pathways linked to unresolved inflammation and airway remodelling characterize the transcriptome in two independent severe asthma cohorts.
    Respirology. 2022 Jun 7. doi: 10.1111/resp.14302.
    PubMed     Abstract available


    February 2022
  58. COUILLARD S, Pavord ID
    Fluticasone furoate: CAPTAIN of fluticasones in type 2 inflammatory asthma.
    Respirology. 2022 Feb 1. doi: 10.1111/resp.14213.
    PubMed    


    January 2022
  59. ZHONG Y, Li L, Chen R, Zheng Q, et al
    Quantitative comparison of dose-effect and time-course of fluticasone furoate and fluticasone propionate in adult and adolescent patients with persistent asthma: A systematic review and meta-analysis.
    Respirology. 2022 Jan 18. doi: 10.1111/resp.14203.
    PubMed     Abstract available


  60. KOONER HK, McIntosh MJ, Desaigoudar V, Rayment JH, et al
    Pulmonary functional MRI: Detecting the structure-function pathologies that drive asthma symptoms and quality of life.
    Respirology. 2022 Jan 10. doi: 10.1111/resp.14197.
    PubMed     Abstract available


  61. LEE JW, Tay TR, Borg BM, Sheriff N, et al
    Laryngeal hypersensitivity and abnormal cough response during mannitol bronchoprovocation challenge.
    Respirology. 2022;27:48-55.
    PubMed     Abstract available


    December 2021
  62. DUAN P, Wang Y, Lin R, Zeng Y, et al
    Impact of early life exposures on COPD in adulthood: A systematic review and meta-analysis.
    Respirology. 2021;26:1131-1151.
    PubMed     Abstract available


    November 2021

  63. P1-10: Indicators of the pituitary-thyroid system in asthma patients with cold airway hyperresponsiveness without manifestation of thyroid lesion, living in endemic goiter area.
    Respirology. 2021;26 Suppl 3:73.
    PubMed    



  64. P1-57: Kartagener's syndrome: A case report of a lady with poorly resolving asthma.
    Respirology. 2021;26 Suppl 3:95-96.
    PubMed    


    October 2021
  65. REDDEL HK, Bacharier LB, Bateman ED, Brightling CE, et al
    Global Initiative for Asthma (GINA) Strategy 2021 - Executive summary and rationale for key changes.
    Respirology. 2021 Oct 19. doi: 10.1111/resp.14174.
    PubMed     Abstract available


  66. WATCHORN D, Menzies-Gow A
    Oral corticosteroid stewardship for asthma: Time to move from theory to routine clinical practice.
    Respirology. 2021 Oct 19. doi: 10.1111/resp.14171.
    PubMed    


  67. MAJELLANO EC, Clark VL, Gibson PG, Foster JM, et al
    The needs and well-being of severe asthma and COPD carers: A cross-sectional study.
    Respirology. 2021 Oct 12. doi: 10.1111/resp.14167.
    PubMed     Abstract available


  68. OKYERE DO, Bui DS, Washko GR, Lodge CJ, et al
    Predictors of lung function trajectories in population-based studies: A systematic review.
    Respirology. 2021;26:938-959.
    PubMed     Abstract available


    September 2021
  69. BLAKEY J, Chung LP, McDonald VM, Ruane L, et al
    Oral corticosteroids stewardship for asthma in adults and adolescents: A position paper from the Thoracic Society of Australia and New Zealand.
    Respirology. 2021 Sep 29. doi: 10.1111/resp.14147.
    PubMed     Abstract available


  70. BERGER P, Dupin I
    Unravelling the effects of omalizumab on fibrocytes.
    Respirology. 2021;26:825-827.
    PubMed    


    April 2021
  71. LANGE P, Ahmed E, Lahmar ZM, Martinez FJ, et al
    Natural history and mechanisms of COPD.
    Respirology. 2021;26:298-321.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Asthma is free of charge.